Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs Steady State Health

PlexusDx
Graded #162

Higher grade

vs+12.800000000000004
Steady State Health
Graded #452

Lower grade

The verdict

PlexusDx takes it — 67.7/100 to 54.9/100.

PlexusDx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlexusDx +29
74
45
Dose & formulationPlexusDx +24
64
40
Clinical oversightSteady State Health +4
74
78
Labs & monitoringEven
52
52
FulfillmentPlexusDx +13
78
65
Contract termsEven
55
55
PlexusDx · left barSteady State Health · right bar

The numbers

MetricPlexusDxSteady State Health
WeighScore67.7/10054.9/100
GradeCC
Scorecard rank#162#452
Semaglutide$149/mo (starting dose, compounded)Not disclosed
Tirzepatide$249/mo (starting dose, compounded)Not disclosed
CoverageAll 50 states2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
PlexusDx

Graded #162 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted
Steady State Health

Graded #452 · C

Strengths

  • Prescribes semaglutide or tirzepatide within a perimenopause and menopause hormone-and-metabolic care plan
  • Care delivered by a named women's-health nurse practitioner (Josie Cowburn, DNP, FNP-C)
  • Transparent flat program fee from $139/mo, with a $99/mo standalone GLP-1 support option

Where it loses points

  • Available only to Oregon and Washington residents
  • GLP-1 medication is billed separately by the pharmacy and not included in the program fee
  • Dispensing pharmacy is not publicly named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard